German rise in colonoscopies curbs intestinal cancer
This article was originally published in Clinica
Executive Summary
Since colonoscopy was introduced as a reimbursable procedure in Germany at ten year - intervals for people over the age of 56 last year, there has been an increase of 30% in procedures carried out. The colonoscopies are leading to "an impressive reduction" in the number of deaths resulting from intestinal cancer, said Wolff Schmiegel, director of the Medical University Clinic of Bochum and vice-chairman of the medical advisory council of German Cancer Aid (DKH).
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.